Meet the Team

pH Blueprint pairs clients with a team who possess precisely the experience and expertise needed to pinpoint and understand the nature of the opportunities or challenges our clients face

We leverage decades of domain expertise to approach our engagements pragmatically and open-mindedly and excel at engagements that require analytical rigor against tight timeframes

Rachel Ravens

Co-Founder and Managing Partner

Rachel manages strategic consulting at pH Blueprint, building and transforming global health care companies by focusing on elevating the experience for patients, providers, payers, and partners.

Rachel has 18 years of experience in the Healthcare and Life Sciences sectors. With a background in biomedical engineering and business, she has dedicated her career to bridging healthcare fractions. She has worked with leading academic institutions, health systems, devices, and diagnostic companies to develop strategic relationships, market analysis, reimbursement strategy, product development, and commercial execution.

She was appointed Adjunct Professor at Northwestern Feinberg Medical School and continues to collaborate with her alma mater Columbia University. Prior to pH Blueprint, Rachel ran strategy for diagnostic companies, both domestic and international.

Erik Halvorsen – PhD

Partner

Erik is a Partner at pH Blueprint with 20 years of experience in the Healthcare and Life Sciences sectors as an entrepreneur, investor, founder, operator, and board member.  With a Ph.D. in neuropharmacology and experience in regenerative medicine, drug development, clinical trials, digital health, and medical devices, Erik brings a broad range of knowledge and deep network to his clients.

 Erik has worked with numerous leading academic institutions, medical centers, VCs, disease foundations, pharma, device, and diagnostic companies on a range of financing, M&A, strategic partnership, and licensing transactions. 

As an entrepreneur, Erik has raised millions of dollars and founded/co-founded several companies including therapeutics, clinical genomics, robotics, diagnostics, and AI-focused digital health with a couple of exits to show for it—and hopefully a couple more on the way.  He also launched and ran early-stage life science investment funds in Boston and Houston. Erik has a personal passion for finding better treatments for pediatric diseases and cancers.  

When taking a break from work Erik likes to catch a Chicago Bears game or watch UVA basketball, his alma mater. 

Bridget Dickinson

Analyst

Bridget is an analyst at pH Blueprint focused on providing strategic advisory services for clients in the Healthcare and Life Sciences sectors. Bridget graduated from the University of Texas with a bachelor’s in Public Health and a Master’s in Design in Health. Bridget gained expertise in human-centered design methodologies that wield new approaches to solve some of the most challenging problems in health.

She applies systemic design methods to frame a problem, understand a system, and identify opportunities for design impact and intervention to drive innovation in healthcare. 

Prior to pH Blueprint, she worked with private medical practices, retail clinic services, and research institutions to reshape our healthcare system to better understand and advocate for the needs of all patients.  

Rahul Rathod – MD

Senior Medical Advisor

Rahul Rathod, MD is the Director of Operations and Strategy at Boston Children’s Hospital and is an Associate Professor at Harvard Medical School. Dr. Rathod received his M.D. from Case Western Reserve University School of Medicine. He completed his pediatric residency at Rainbow Babies and Children’s Hospital and his cardiology and advanced imaging fellowship at Boston Children’s Hospital. He is anticipated to receive his M.B.A. from the Massachusetts Institute of Technology in May of 2022.

Dr. Rathod possesses over 20 years of experience in healthcare operations, medical technology, and program development. He is an experienced entrepreneur and intrapreneur, identifying systems issues and building tech-enabled solutions that increase efficiency organization-wide. Dr. Rathod has authored over 60+ publications and is an internationally recognized key opinion leader and medical expert. Previously, he founded and served as the Chief Executive Officer at NextMed Technologies, a medical technology company improving physician communication and handoff software solutions for hospital systems, residency programs, and physician groups. Dr. Rathod is known for his unique ability to leverage clinical, operational, and IT experience for unique and executable solutions to real-world problems.

Animesh Tandon – MD

Senior Medical Advisor

Animesh (Aashoo) Tandon, MD, MS, is the Director of Cardiac Innovation (Pediatrics) and the Clinical Innovation Lead (Pediatrics) at the Cleveland Clinic. He graduated from Washington University in St. Louis with a BA in 2003. During his medical training at the University of Michigan Medical School, he performed a research fellowship at the NINDS/NIH through the Howard Hughes Medical Institute/NIH Research Scholars (Cloister) Program. Dr. Tandon completed his pediatric residency and categorical pediatric cardiology fellowship at Cincinnati Children’s Hospital Medical Center. During his fellowship, he earned a Master’s in Clinical and Translational Research from the University of Cincinnati. He then completed an advanced imaging fellowship at Children’s Healthcare of Atlanta/Emory University.

His current clinical and research interests are focused on the use of cardiac MRI (CMR) in congenital heart disease; the development and use of wearable biosensors and other monitoring devices; the collection and analysis of big data through machine learning and the development of predictive analytics; 3D printing, 3D visualization, virtual reality, and augmented reality in congenital heart disease; and fellow education. He is especially passionate about bringing technology to children’s medical needs.

He is heavily involved in innovation and mentorship at a national level. He has leadership roles in the American Heart Association Center for Health Technology & Innovation (CHTI) Health Technology Advisory Group (HTAG); the American Academy of Pediatrics; the Society of Cardiovascular Magnetic Resonance; and previously at the American College of Cardiology.

Ashok Gowda – PhD

Medical Device Advisor

Dr. Gowda is the founder and CEO of the Houston-based medical technology developer and manufacturer, Biotex, Inc. To date, under his direction, the company has raised over $25M in non-dilutive funding, successfully licensed numerous early-stage technologies, spun out three separate companies (Visualase, Inc., Base Pair Biotechnologies, Inc., E-SAFE Medical, Inc.), incubated multiple medical device startups, and most recently launched an early-stage medical device fund. Dr. Gowda oversees development programs as well as partnering activities, where the company works with physicians, entrepreneurs, and start-ups to develop and bring to market their new medical device ideas. Previously, Dr. Gowda co-founded and served as President, and Chief Operating Officer at Visualase, Inc., which was acquired by Medtronic for $100M in 2014.

Dr. Gowda is an active investor, advisor, and board member for a number of early-stage medical technology companies. Dr. Gowda has served as principal investigator on more than 15 NIH grants, authored more than 50 peer-reviewed publications and abstracts, and is an inventor on more than 25 issued patents. Dr. Gowda received his Bachelor of Engineering degree in Biomedical Engineering from Vanderbilt University and the M.S. and Ph.D. degrees in Bioengineering from Texas A&M University.

Rachel Ravens

Co-Founder and Managing Partner  

Rachel manages strategic consulting at pH Blueprint, building and transforming global health care companies by focusing on elevating the experience for patients, providers, payers, and partners.

Rachel has 18 years of experience in the Healthcare and Life Sciences sectors. With a background in biomedical engineering and business, she has dedicated her career to bridging healthcare fractions. She has worked with leading academic institutions, health systems, devices, and diagnostic companies to develop strategic relationships, market analysis, reimbursement strategy, product development, and commercial execution.

She was appointed Adjunct Professor at Northwestern Feinberg Medical School and continues to collaborate with her alma mater Columbia University. Prior to pH Blueprint, Rachel ran strategy for diagnostic companies, both domestic and international.

Erik Halvorsen – PhD

Partner

Erik is a Partner at pH Blueprint with 20 years of experience in the Healthcare and Life Sciences sectors as an entrepreneur, investor, founder, operator, and board member.  With a Ph.D. in neuropharmacology and experience in regenerative medicine, drug development, clinical trials, digital health, and medical devices, Erik brings a broad range of knowledge and deep network to his clients.

Erik has worked with numerous leading academic institutions, medical centers, VCs, disease foundations, pharma, device, and diagnostic companies on a range of financing, M&A, strategic partnership, and licensing transactions.

As an entrepreneur, Erik has raised millions of dollars and founded/co-founded several companies including therapeutics, clinical genomics, robotics, diagnostics, and AI-focused digital health with a couple of exits to show for it—and hopefully a couple more on the way.  He also launched and ran early-stage life science investment funds in Boston and Houston. Erik has a personal passion for finding better treatments for pediatric diseases and cancers.

When taking a break from work Erik likes to catch a Chicago Bears game or watch UVA basketball, his alma mater.

Bridget Dickinson

Analyst

Bridget is an analyst at pH Blueprint focused on providing strategic advisory services for clients in the Healthcare and Life Sciences sectors. Bridget graduated from the University of Texas with a bachelor’s in Public Health and a Master’s in Design in Health. Bridget gained expertise in human-centered design methodologies that wield new approaches to solve some of the most challenging problems in health.

She applies systemic design methods to frame a problem, understand a system, and identify opportunities for design impact and intervention to drive innovation in healthcare. 

Prior to pH Blueprint, she worked with private medical practices, retail clinic services, and research institutions to reshape our healthcare system to better understand and advocate for the needs of all patients.  

Rahul Rathod – MD

Senior Medical Advisor

Rahul Rathod, MD is the Director of Operations and Strategy at Boston Children’s Hospital and is an Associate Professor at Harvard Medical School. Dr. Rathod received his M.D. from Case Western Reserve University School of Medicine. He completed his pediatric residency at Rainbow Babies and Children’s Hospital and his cardiology and advanced imaging fellowship at Boston Children’s Hospital. He is anticipated to receive his M.B.A. from the Massachusetts Institute of Technology in May of 2022.

Dr. Rathod possesses over 20 years of experience in healthcare operations, medical technology, and program development. He is an experienced entrepreneur and intrapreneur, identifying systems issues and building tech-enabled solutions that increase efficiency organization-wide. Dr. Rathod has authored over 60+ publications and is an internationally recognized key opinion leader and medical expert. Previously, he founded and served as the Chief Executive Officer at NextMed Technologies, a medical technology company improving physician communication and handoff software solutions for hospital systems, residency programs, and physician groups. Dr. Rathod is known for his unique ability to leverage clinical, operational, and IT experience for unique and executable solutions to real-world problems.

Animesh Tandon – MD

Senior Medical Advisor

Animesh (Aashoo) Tandon, MD, MS, is an Assistant Professor of Pediatrics, with a joint appointment in Radiology, and faculty in Biomedical Engineering, at UT Southwestern. He graduated from Washington University in St. Louis with a BA in 2003. During his medical training at the University of Michigan Medical School, he performed a research fellowship at the NINDS/NIH through the Howard Hughes Medical Institute/NIH Research Scholars (Cloister) Program. Dr. Tandon completed his pediatric residency and categorical pediatric cardiology fellowship at Cincinnati Children’s Hospital Medical Center. During his fellowship, he earned a Master’s in Clinical and Translational Research from the University of Cincinnati. He then completed an advanced imaging fellowship at Children’s Healthcare of Atlanta/Emory University.

His current clinical and research interests are focused on the use of cardiac MRI (CMR) in congenital heart disease; the development and use of wearable biosensors and other monitoring devices; the collection and analysis of big data through machine learning and the development of predictive analytics; 3D printing, 3D visualization, virtual reality, and augmented reality in congenital heart disease; and fellow education. He is especially passionate about bringing technology to children’s medical needs.

He is heavily involved in innovation and mentorship at a national level. He has leadership roles in the American Heart Association Center for Health Technology & Innovation (CHTI) Health Technology Advisory Group (HTAG); the American Academy of Pediatrics; the Society of Cardiovascular Magnetic Resonance; and previously at the American College of Cardiology.

Ashok Gowda – PhD

Medical Device Advisor

Dr. Gowda is the founder and CEO of the Houston-based medical technology developer and manufacturer, Biotex, Inc. To date, under his direction, the company has raised over $25M in non-dilutive funding, successfully licensed numerous early-stage technologies, spun out three separate companies (Visualase, Inc., Base Pair Biotechnologies, Inc., E-SAFE Medical, Inc.), incubated multiple medical device startups, and most recently launched an early-stage medical device fund. Dr. Gowda oversees development programs as well as partnering activities, where the company works with physicians, entrepreneurs, and start-ups to develop and bring to market their new medical device ideas. Previously, Dr. Gowda co-founded and served as President, and Chief Operating Officer at Visualase, Inc., which was acquired by Medtronic for $100M in 2014.

Dr. Gowda is an active investor, advisor, and board member for a number of early-stage medical technology companies. Dr. Gowda has served as principal investigator on more than 15 NIH grants, authored more than 50 peer-reviewed publications and abstracts, and is an inventor on more than 25 issued patents. Dr. Gowda received his Bachelor of Engineering degree in Biomedical Engineering from Vanderbilt University and the M.S. and Ph.D. degrees in Bioengineering from Texas A&M University.

Evelyn Nordin

Financial Strategist 

Evelyn provides financial and operational planning services for pH Blueprint clients, complementing the product and technical advisory provided by the rest of the team.  Evelyn develops the “financial story” that must accompany the “innovation story” for healthcare companies looking to grow.

Evelyn has over 20 years helping companies develop financial strategy and infrastructure; navigate debt and equity capital markets; and effectively communicate with external stakeholders.

She has gravitated toward challenging roles that require both technical and strategic expertise to help companies operate in volatile or emerging industries.  She spent a decade in IT, over a decade in oilfield services, and more recently has extended into biotech.

Suresh Pisharody 

Senior Advisor

Suresh Pisharody is a seasoned executive in the Life Sciences Tools, Genomics, and Precision Medicine Industry. He has held senior leadership positions at a number of world-class companies including Illumina, ThermoFisher, and Guardant Health. His teams have been responsible for introducing some of the most transformational and successful products in the Genomics and Precision Medicine Space.

He has a sound record of success in start-up and established organizations. Suresh is adept at leveraging cross functional teams to accelerate product innovations and build great brands. He is an authentic, visionary leader with a unique combination of technical, commercial and people skills and a proven track record of building world-class businesses and teams.

His area of expertise includes Entrepreneurship, Lifecycle management, Product and Portfolio Strategy, Market Access, Brand Management, P&L management, and R&D over a successful leadership career of over 20 years. 

Meg Barron – MBA

Senior Digital Health Advisor

 
Meg is the Vice President of Digital Health Innovations at the American Medical Association. Meg is passionate about driving change by collaborating with physicians, technology leaders and solution innovators to improve health care. She has served in product development and business development leadership roles and most recently is responsible for driving the roadmap of initiatives that support the AMA’s digital health and medicine strategy. In addition, she has led partnerships and innovation related initiatives, such as the inaugural AMA Healthier Nation Innovation Challenge, the establishment of the AMA Interaction Studio at MATTER, the AMA Physician Innovation Network that enables entrepreneurs and physicians to collaborate on the development of new solutions, the AMA Digital Health & Telehealth Implementation Playbook series, AMA Digital Health national research, The Telehealth Initiativeand The AMA Telehealth Immersion Program with collaborators. She participates on the Advisory Board for MATTER, MassChallenge HealthTech,Together.Health and as a TEDMed Research Scholar. She participates on the Editorial Review Board of The Telehealth and Medicine Today Journal. She is also a recent member of CHIEF – a private membership focused on connecting and supporting women executive leaders. 

Meg has spoken at national conferences such as Health 2.0, Connected Health, HLTH, American Telemedicine Association National Conference, HIMSS, National Health IT Summit, DTx East and contributes as speaking faculty for Columbia Business School’s Digital Health program curriculum. She has articles published in Health Affairs, Harvard Business Review and Nature Digital Medicine. 

Prior to AMA, Meg worked in the Consumer Product & Retail vertical at Capgemini and at SmithBucklin Corporation for various business and health care clients. She has experience creating a company through support at Built in Chicago and 1871 in Chicago; her company received acknowledgement by Crain’s Chicago, Chicago Ideas Week and was listed as one of the 24 Coolest New Businesses in Chicago by Business Insider. When not focused on improving healthcare, she can usually be found home remodeling, at a concert or spending time with family.

Dianalee McKnight – PhD, FACMG

Senior Genomics Advisor

Dr. Dianalee McKnight is board-certified in clinical molecular genetics by the American Board of Medical Genetics and Genomics. She has more than 10 years of experience in the genetic diagnostics field and is currently a Medical Affairs Director at Invitae. Prior to joining Invitae, Dr. McKnight was the director of the neurogenetics testing program at GeneDx, where she specialized in genetic testing for pediatric patients with epilepsy and intellectual disability. Dr. McKnight is also the co-chair of the NIH ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel. She has reviewed and reported genetic testing results for tens of thousands of individuals with various neurological conditions. Additionally, she has extensive experience developing clinical diagnostic tests using advanced technologies such as arrays, next-generation sequencing panels, exome and genome sequencing.

Dr. McKnight continues to be involved with cutting edge technologies and bioinformatics as the field of genomics and diagnostics continues to evolve. Dr. McKnight earned her doctorate degree at Penn State University and completed post-doctoral training at the NIH. While at the NIH, she was a research fellow at the National Institute of Dental and Craniofacial Research for 5 years, during which she also completed her board-accredited clinical molecular genetics training fellowship at the National Human Genome Research Institute.

Kyle Retterer

Senior Genomics Advisor

Kyle is the VP of Genomics at Geisinger. Prior to joining Geisinger, Kyle served as the Chief Technology Officer and Chief Innovation Officer at GeneDx, a genetic diagnostics company. Retterer was with GeneDx for 12 years and has helped build the technological platform that enables geneticists to go from sequencing individual genes to performing whole genome sequencing. Kyle believes gathering data will help us learn, improve diagnosis for our patients, and advance our general understanding of genetic disease.

Austin, TX | New York, NY

info@phblueprint.com
2208 Lake Austin Boulevard | 1st Floor
Austin, TX 78703